Ideas alone don’t save lives.

They need researchers willing to ask difficult questions, clinicians who understand patients’ needs, industry partners that can manufacture new therapies, governments willing to invest and philanthropic partners willing to believe in possibilities long before outcomes are certain.

In other words, they need an ecosystem.

At UBC, donors are helping build that ecosystem through Canada’s Immuno-Engineering and Biomanufacturing Hub (CIEBH)—a national health research collaboration, hosted by UBC, to accelerate the journey from scientific discovery to real-world care.

Early philanthropic support led UBC’s research leadership to develop the vision for CIEBH. The investment made the vision feasible and helped underpin the business case for CIEBH, recruit expertise and forge partnerships that ultimately attracted major provincial and federal funding. The gift laid the foundation for one of Canada’s most ambitious biotechnology initiatives.

Specifically, a gift for the Advanced Therapeutics Manufacturing Facility (ATMF), currently under construction at UBC’s Vancouver campus, generated philanthropic momentum that helped launch CIEBH.

Purpose-built to manufacture advanced cell and gene therapies, the ATMF will become the first facility of its kind in Western Canada focused on early-stage clinical trials, providing researchers and biotechnology companies with the specialized environment needed to move promising discoveries forward.

“The ATMF will give researchers and biotech startups the ability to manufacture advanced, clinical-grade therapies right here in BC, instead of sending promising discoveries out of the province,” says Dr. Megan Levings, ATMF co-director. “That means keeping more Canadian science in Canada—powering up BC’s life sciences sector with discoveries, skilled talent, new companies and jobs—while also accelerating translation from the lab to clinic so patients have access to lifesaving treatments sooner.”

The impact extends beyond the laboratory. By giving researchers and entrepreneurs the infrastructure they need to commercialize discoveries in BC, the ATMF will help attract investment and power BC’s biotech boom, one of the province’s fastest-growing industries.

“CIEBH is really the connective tissue,” says Dr. Michelle Wong, Executive Director, CIEBH and Senior Director, Research, Faculty of Medicine. “It’s the glue that brings together academic institutions, industry partners, healthcare organizations, governments and community organizations so we can build those relationships in a way that creates real impact.”

Every organization involved in health research has unique expertise. Individually, each plays an important role. Together, they can accomplish something far greater.

“When we’re working together,” says Dr. Wong, “we create better-informed care. The feedback we receive from clinicians helps shape the research questions we’re asking, which ultimately leads to more effective, and increasingly personalized, treatments.”

For that reason, philanthropy plays a unique role.

While traditional funding often supports established research, donor support gives researchers the confidence to pursue bold ideas and invest in promising opportunities earlier. And it helps create an ecosystem that benefits all the researchers working within it—building the partnerships that allow innovation to flourish.

“Philanthropy has always been a key partner in driving research and innovation forward,” says Dr. Wong. “Donors bring a unique perspective. They help us identify gaps in the system and ask important questions that researchers or healthcare providers may not always see. Together, we’re building an ecosystem that creates momentum.”

Looking ahead, Dr. Wong believes BC has everything needed to become an internationally recognized biotechnology leader: world-class researchers, advanced infrastructure, an industry-ready workforce and strong partnerships across academia, healthcare, industry and government.

“The real strength of BC is our culture of collaboration,” says Dr. Wong. “We’re bringing together the right people, from the right sectors, to solve problems together. That’s what’s creating an innovation ecosystem—and that’s what’s going to make the difference pushing forward.”

Learn more about UBC’s biotech research.